MedEngine, a premium service provider for pharmaceutical and health technology industries, reports a strong financial result in 2017. The company’s revenue grew 61% to 1.6…
A recently published real-world cohort study demonstrated that vedolizumab, an anti-integrin antibody, is an effective and well-tolerated treatment option for patients with inflammatory bowel disease (IBD). The…
The MedEngine team is growing yet again! Allow us to introduce Mirkka Koivusalo, Heidi Loponen, and Hanni Uusi-Kerttula, who joined MedEngine in October—and have already…
Over the past 10 years, medical affairs has lifted its profile probably more than any other function in the pharmaceutical industry. Currently, medical affairs is…
The 20th Annual European Congress of The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) was held in Glasgow, Scotland on Nov 4–8th 2017. The event attracted…
A recent study published in Community Dental Health reveals that Finnish dentists find smoking cessation important but seldom provide concrete withdrawal guidance. It is well known that…
Our team is expanding again! We are proud to introduce Hanna Ala-Hongistoand Kaisa Kaitila, the latest experts to join us, starting as our new Scientific Project Managers.…
The entire pharmaceutical industry is built on various forms of data and has recently invested substantial resources towards collecting and analyzing real-world data (RWD). RWD has traditionally…